Debt-to-equity of Deciphera Pharmaceuticals, Inc. from 30 Sep 2018 to 31 Mar 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Deciphera Pharmaceuticals, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2018 to 31 Mar 2024.
  • Deciphera Pharmaceuticals, Inc. Debt-to-equity for the quarter ending 31 Mar 2024 was 31%, a 13% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Deciphera Pharmaceuticals, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q1 2024 31% +3.6% +13% 31 Mar 2024
Q4 2023 29% -2.2% -7.1% 31 Dec 2023
Q3 2023 28% -4.4% -14% 30 Sep 2023
Q2 2023 27% -5.1% -16% 30 Jun 2023
Q1 2023 27% -3.8% -12% 31 Mar 2023
Q4 2022 31% +5.6% +22% 31 Dec 2022
Q3 2022 33% +12% +58% 30 Sep 2022
Q2 2022 33% +14% +79% 30 Jun 2022
Q1 2022 31% +15% +99% 31 Mar 2022
Q4 2021 25% +12% +92% 31 Dec 2021
Q3 2021 21% +8.5% +70% 30 Sep 2021
Q2 2021 18% +8.1% +80% 30 Jun 2021
Q1 2021 16% +4.9% +46% 31 Mar 2021
Q4 2020 13% +1.6% +14% 31 Dec 2020
Q3 2020 12% +1.3% +12% 30 Sep 2020
Q2 2020 10% -3.1% -23% 30 Jun 2020
Q1 2020 11% -1.3% -11% 31 Mar 2020
Q4 2019 12% -0.11% -0.94% 31 Dec 2019
Q3 2019 11% +0.11% +1% 30 Sep 2019
Q2 2019 13% 30 Jun 2019
Q1 2019 12% 31 Mar 2019
Q4 2018 12% 31 Dec 2018
Q3 2018 11% 30 Sep 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.